Search
Feed aggregator
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report 6/6/2024
Embracing Inclusivity: How Biopharmas Connect With LGBTQ+ Employees
Embracing Inclusivity: How Biopharmas Connect With LGBTQ+ Employees 6/6/2024
Telix Targets $200M IPO in Hot Radiopharma Market as Biotech Nasdaq Offerings Slow
Telix Targets $200M IPO in Hot Radiopharma Market as Biotech Nasdaq Offerings Slow 6/6/2024
You’re More Than Your Job: Finding Self-Worth Outside of Work
You’re More Than Your Job: Finding Self-Worth Outside of Work 6/6/2024
ASGCT 2024 Comes at Pivotal Time for Gene and Cell Therapy Sector
ASGCT 2024 Comes at Pivotal Time for Gene and Cell Therapy Sector 5/6/2024
Opinion: Can Ketamine Be Safely Used at Home?
Opinion: Can Ketamine Be Safely Used at Home? 5/6/2024
5 DMD Data Readouts to Watch in 2024
5 DMD Data Readouts to Watch in 2024 5/6/2024
AAVs in Focus at ASGCT: Improved Precision, Targeting Common Diseases
AAVs in Focus at ASGCT: Improved Precision, Targeting Common Diseases 5/6/2024
FDA Greenlights BMS, J&J CAR-T Therapies for Earlier Multiple Myeloma Treatment
FDA Greenlights BMS, J&J CAR-T Therapies for Earlier Multiple Myeloma Treatment 4/6/2024
ASCO24: Novartis Leukemia Drug Beats Older Drugs in Phase III Readout
ASCO24: Novartis Leukemia Drug Beats Older Drugs in Phase III Readout 5/31/2024
Gilead’s Trodelvy Fails to Reach Primary Endpoint in Confirmatory Trial
Gilead’s Trodelvy Fails to Reach Primary Endpoint in Confirmatory Trial 5/31/2024
FDA Delays Dupixent Uncontrolled COPD Decision as EU Panel Recommends Approval
FDA Delays Dupixent Uncontrolled COPD Decision as EU Panel Recommends Approval 5/31/2024
ASCO24 Preview: A Look at Some of the Cancer Meeting’s Hottest Abstracts
ASCO24 Preview: A Look at Some of the Cancer Meeting’s Hottest Abstracts 5/31/2024
Smaller Biopharma M&A on Upswing, Deals Expected to Continue Through 2024
Smaller Biopharma M&A on Upswing, Deals Expected to Continue Through 2024 5/31/2024
BridgeBio Builds on Positive Phase III Data for Acoramidis in ATTR-CM
BridgeBio Builds on Positive Phase III Data for Acoramidis in ATTR-CM 5/30/2024
Immunovant Shifts Focus to Other FcRn Inhibitor, Gives Rival Vyvgart Breathing Room
Immunovant Shifts Focus to Other FcRn Inhibitor, Gives Rival Vyvgart Breathing Room 5/30/2024
Tris Pharma Gets FDA Approval for Non-Stimulant ADHD Medication
Tris Pharma Gets FDA Approval for Non-Stimulant ADHD Medication 5/30/2024
Biohaven’s Phase I Data for Lead Protein Degrader Disappoints Investors
Biohaven’s Phase I Data for Lead Protein Degrader Disappoints Investors 5/30/2024
BioSpace x DIA: Advanced Therapy Product Regulatory Confusion
BioSpace x DIA: Advanced Therapy Product Regulatory Confusion 5/30/2024
BioNTech Secures $145M to Boost mRNA Vaccine Capabilities in Africa
BioNTech Secures $145M to Boost mRNA Vaccine Capabilities in Africa 5/30/2024
World Pharma News
- AI-assisted approach identifies IRS4 as a promising drug target in multiple solid tumors
- Researchers identify natural compound that disarms drug-resistant bacteria
- Scientists discover a new way to make drug-resistant cancer treatable again
- A new drug concept to treat obesity and type 2 diabetes
- Autonomous AI-based drug prescribing rife with potential problems